The Division of Medical Oncology evaluates and treats patients with all forms of cancer. An internationally renowned faculty participates in multidisciplinary approaches for the evaluation and treatment of patients with cancers of the lung, colon and rectum, breast, pancreas, stomach, esophagus, prostate, bladder, head and neck, melanoma, leukemias, lumphomas and multiple myeloma. Autologous and Allogeneic bone marrow transplantations are performed for selected forms of cancer.

Vaccine development and other forms of immunotherapy are under active investigation. Clinical trials research, as well as translational cancer research from the laboratories of the Kimmel Cancer Center, is focused on the development of new treatments and diagnostic methods. Innovative therapies are undergoing evaluation in collaboration with the National Cancer Institute, various pharmaceutical companies and programs developed at the Kimmel Cancer Center.